|
European Medicines Agency workshop: bees needs medicines too The problems in the bee-keeping sector and the decline in the bee population all over Europe and the world are complex and diverse. The availability of veterinary medicines for bees remains a major concern. The European Medicines Agency held a workshop entitled “Medicines for bees - What the Agency can do to increase availability” on 14-15 December 2009.
The workshop brought together experts from the bee keeping and honey production sector, experts in bee diseases and treatment of bees, representatives from the regulatory authorities of Member States, the European Commission, the animal health industry and other interested parties. It provided the opportunity to discuss possible approaches forward to identify the most needed treatment options for bees. The aim of the workshop was to try and identify a list of substances that are essential for the treatment of bee diseases in Europe. Animal Health companies represented by IFAH-Europe presented the issues they are confronted with when researching and developing veterinary products for bees, a relatively small market where most of the suitable medicines are old, therefore not eligible for data protection. IFAH-Europe presented three case studies and complemented the presentation by the Association of Veterinary Consultants (AVC) on the actual situation and the possible solutions to increase availability of veterinary products for bees. IFAH-Europe recognises the value of bees for the environment and society and is committed to contributing to the protection of a small but essential species. The agenda and background document of the European Medicines Agency workshop are available online. Save the date: IFAH-EUROPE annual conference 2010 "Animal health & the food security challenge" This year, the IFAH-Europe conference aims to bring together key European opinion leaders, decision makers and food chain stakeholders to discuss the food security challenge and to contribute to a common understanding of the role of animal health in supporting the supply of safe and abundant animal protein. The conference will be held at the Renaissance Brussels Hotel on Thursday 10 June 2010. We encourage you all to mark your agendas for one of the main events of the year in the animal health sector. More information and a draft programme will be made available on the IFAH-Europe website’s Events section in due course. Please contact Myriam Alcain, Communications Manager, for more information: m.alcain@ifahsec.org France launches website on veterinary medicines  IFAH-Europe’s French member association SIMV* launched a website dedicated to veterinary medicines, www.merci-les-medicaments-veterinaires.com (“Thank-you-veterinary-medicines“). What is a veterinary medicine? How are they used to treat animals? Is an environmental impact assessment carried out? Companies from the French veterinary medicines industry joined forces to create a website answering all these questions and more. The purpose of this website is to offer a vast amount of information about veterinary medicines from their conception to their placement on the market, while dealing with more specific issues such as the position of the industry, initiatives undertaken in favour of animal welfare and increase medicines’ availability for animals, safety issues related to products and their use, minor species… Testimonies are also featured introducing the men and women who, through their daily activities, contribute to bringing new solutions for veterinary surgeons to prevent and cure diseases. This joint endeavour of the French veterinary medicines industry marks a decisive step in their communication activities to provide accurate and pedagogical information about their products and their efforts to research, develop and register new products. Understanding the current and future issues at stake for the animal health market is fundamental to maintain and develop quality therapeutic tools. *SIMV stands for « Syndicat de l’Industrie du Médicament Vétérinaire et Réactifs» and represents laboratories responsible for bringing animal medicines on the French market. More information at www.simv.org
IFAH-Europe publishes statement on Q-fever Q-fever is a very contagious zoonotic disease which can infect humans, caused by the bacterial pathogen Coxiella burnetti. It is found across Europe, although at the end of 2009 there was a particular increase in the Netherlands, where the government took measures to deal with the situation.
See the full IFAH-statement, with useful links on the disease.
|